Analysis of brain tissue lysates and immunohistochemistry of pathology-susceptible brain regions demonstrate that pS106-Rab12 levels are increased in Dementia with Lewy bodies (DLB), Alzheimer’s disease (AD), and PD, and in LRRK2 mutation carriers. This evidence concerns the gene LRRK2 and Parkinson disease.